♟️ Thursday 31 July 2025 Thu, 31 July 2025

Verity Resources has identified a new gold mineralised trend near its Monument Gold Project and commenced a significant drilling program to upgrade its Korong deposit resource. Meanwhile, high-grade rare earth elements have been confirmed at its Pimenta project in Brazil.

betr Entertainment Limited has boosted its all-scrip takeover offer for PointsBet while reporting a strong Q4 FY25 with $70 million EBITDA profit, underpinned by robust growth and strategic integrations.

Metgasco reports a 4% dip in quarterly sales revenue and a 9% drop in production, while launching a Production Uplift Program funded by a $750,000 capital raise. Operational improvements at Odin and Vali fields helped slow the decline.

Maronan Metals has significantly upgraded its Maronan deposit resource, doubling indicated silver-lead tonnage and adding near-surface copper-gold resources, setting the stage for imminent economic assessment results and development progress.

Global Uranium and Enrichment Limited has completed a transformative acquisition of the Pine Ridge Uranium Project in Wyoming, initiating a large-scale drilling program that positions the company as a key domestic uranium developer in the US.

Axel REE Limited reports exceptional high-grade gallium and rare earth element mineralisation across a vast area at its Caladão Project, with promising metallurgical test results supporting low-cost extraction methods.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

Critical Minerals Group (CMG) has made significant strides in its vanadium battery energy storage solutions and upstream mine development, supported by a $2.7 million entitlement offer. The company is targeting delivery of vanadium flow battery projects by 2026 amid growing demand for long-duration energy storage in Australia.

Winchester Energy Limited has resumed trading on the ASX following confirmation that it now meets director requirements under the Corporations Act. This development ends a trading suspension tied to governance compliance.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Winchester Energy has appointed Jason Peterson and David Wheeler as non-executive directors, restoring its board to the required three members and addressing recent regulatory notices.

Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.

Core Energy Minerals has initiated its first aircore drilling program at the Cummins Uranium Project in South Australia, while confirming uranium mineralisation in Brazil and refinancing its convertible notes to support ongoing exploration.

Ionic Rare Earths advances its rare earths strategy with major UK government funding, Brazilian JV progress, and US expansion talks amid China export controls.

Micro-X has landed a significant supply agreement with a top US healthcare provider for its Rover Plus mobile X-ray units, while progressing clinical trials and development milestones for its innovative CT imaging products.

Electro Optic Systems (EOS) has secured its largest-ever order for the Slinger Counter-Drone system, boosting its contract backlog by 25% to $170 million and reporting strong cash flow and a debt-free balance sheet.

Odessa Minerals reports encouraging base metal anomalies and uranium exploration progress at its Lyndon Project, alongside strategic board changes and ongoing acquisition reviews.

Volt Group reported a 15% decline in Q2 FY25 revenue due to customer order timing delays but secured new Wescone orders pointing to a strong Q3 recovery. Meanwhile, EcoQuip and ATEN projects advanced with promising demonstrations and feasibility studies.

Livium Ltd reported a modest net profit in its battery recycling division for Q4 FY25, while securing significant new contracts and progressing lithium extraction technology development.

Brightstar Resources has delivered a strong Definitive Feasibility Study for its Laverton and Menzies Gold Projects, targeting over 338,000 ounces of gold with promising financial returns, while ramping up underground mining operations and securing $50 million in capital.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.